Development of a novel therapy for Lipo‐oligosaccharide‐induced experimental neuritis: use of peptide glycomimics
Open Access
- 16 March 2010
- journal article
- Published by Wiley in Journal of Neurochemistry
- Vol. 113 (2), 351-362
- https://doi.org/10.1111/j.1471-4159.2010.06627.x
Abstract
J. Neurochem. (2010) 113, 351–362. Abstract Recent etiological studies have revealed that molecular mimicry between the lipo-oligosaccharide (LOS) component of Campylobacter jejuni and gangliosides of peripheral nervous system plays an important role in the pathogenesis of Guillain-Barré syndrome (GBS). Previously, we demonstrated GD3 ganglioside molecular mimicry in a model of GBS in Lewis rats by sensitization with GD3-like LOS (LOSGD3) from C. jejuni. Since the neuropathophysiological consequences were due largely to the anti-GD3-like antibodies, we subsequently focused our effort upon eliminating the pathogenic antibodies using several strategies to mimic GD3 in this model. Here, we have validated this strategy by the use of peptide glycomimics based on epitopic mimicry between carbohydrates and peptides. We treated rats by i.p. administration of phage-displayed GD3-like peptides. One GD3-like peptide (PGD3-4; RHAYRSMAEWGFLYS) induced in treated rats a remarkable restoration of motor nerve functions, as evidenced by improved histopathology, rotarod performance, and motor nerve conduction velocity. PGD3-4 effectively decreased the titer of anti-GD3/anti-LOSGD3 antibodies and ameliorated peripheral nerve dysfunction in the sera of treated rats. The data suggest that peptide glycomimics of ganglioside may be potential powerful reagents for therapeutic intervention in GBS by neutralizing specific pathogenic anti-ganglioside antibodies.Keywords
This publication has 42 references indexed in Scilit:
- Novel anti‐idiotype antibody therapy for lipooligosaccharide‐induced experimental autoimmune neuritis: Use relevant to Guillain‐Barré syndromeJournal of Neuroscience Research, 2010
- Antiganglioside antibodies and their pathophysiological effects on Guillain-Barre syndrome and related disorders--A reviewGlycobiology, 2009
- Functional role of glycosphingolipids and gangliosides in control of cell adhesion, motility, and growth, through glycosynaptic microdomainsBiochimica et Biophysica Acta (BBA) - General Subjects, 2008
- Ganglioside mimicry and peripheral nerve diseaseMuscle & Nerve, 2007
- Ganglioside Molecular Mimicry and Its Pathological Roles in Guillain-Barré Syndrome and Related DiseasesInfection and Immunity, 2006
- GD3‐replica peptides selected from a phage peptide library induce a GD3 ganglioside antibody responseFEBS Letters, 2006
- Antiglycolipid antibodies in Guillain-Barré syndrome and related diseases: Review of clinical features and antibody specificitiesJournal of Neuroscience Research, 2005
- Identification of a peptide mimic of the L2/HNK‐1 carbohydrate epitopeJournal of Neurochemistry, 2002
- SWISS‐MODEL and the Swiss‐Pdb Viewer: An environment for comparative protein modelingElectrophoresis, 1997
- Induction of IgG antibodies against GD3 ganglioside in rabbits by an anti-idiotypic monoclonal antibody.JCI Insight, 1991